You have no items in your shopping cart.
Search results for: 'SARS-CoV-2'
SARS-CoV-2 Trimeric Spike UK VOC 202012/01 (alpha) [orb1108518]410 kDa; Protein contains amino acids 14-1211 and following mutations: HV 69-70 del, Y144 del, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H. Plus two extra amino acids (AS) in N-terminus, trimerization domain and His-6 tag at C-terminus, GS linker between protein and trimerization domain and GSG linker between trimerization domain and His-tag. Furin cleavage (RRAR) site between Spike S1 and S2 is mutated (GSAS). Also, two stabilizing prolines (PP) have been added to the S2 domain.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg409.7 kDa; Protein contains amino acids 14-1211 and following mutations: L18F, D80A, D215G, LAL 242-244 del, R246I, K417N, E484K, N501Y, D614G, A701V. Plus two extra amino acids (AS) in N-terminus, trimerization domain and His-6 tag at C-terminus, GS linker between protein and trimerization domain and GSG linker between trimerization domain and His-tag. Furin cleavage (RRAR) site between Spike S1 and S2 is mutated (GSAS). Also, two stabilizing prolines (PP) have been added to the S2 domain.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 100 μg, 10 μg- SARS-CoV-2 Spike RBD2 Brazil P1 (gamma) [orb1108520]
28.4 kDa; Protein contains amino acids 319-541, mutations K417T, E484K, N501Y, plus two extra amino acids (YS) in N-terminus and His-6 tag at C-terminus and GSG linker between protein and tag.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 Spike RBD2 South Africa VOC 501.V2 (beta) [orb1108521]
26.2 kDa; Protein contains amino acids 319-541, mutations K417N, E484K, N501Y, plus two extra amino acids (YS) in N-terminus and His-6 tag at C-terminus and GSG linker between protein and tag.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 Spike RBD2 UK VOC 202012/01 (alpha) [orb1108522]
23.33 kDa; Protein contains amino acids 319-541, mutation N501Y, plus two extra amino acids (YS) in N-terminus and His-6 tag at C-terminus and GSG linker between protein and tag.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 Spike S1 UK VOC 202012/01 (alpha) [orb1108523]
75.56 kDa; Protein contains amino acids 14-681, mutations HV 69-70 del, Y144 del, N501Y, A570D, P681H, D614G, two extra amino acids (AS) in N-terminus and His-6 tag at C-terminus and GSG linker between protein and tag.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 S1 RBD2 [orb1108526]
26,37 kDa; Protein contains amino acids 319-541, plus two extra amino acids (YS) in N-terminus and His-6 tag at C-terminus.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 Spike S2 [orb1108527]
58,82 kDa; Protein contains amino acids 693-1218 and His-6 tag at C-terminus.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 Spike S1 [orb1108528]
76,42 kDa; Protein contains amino acids 14-681, two extra amino acids (AS) in N-terminus and His-6 tag at C-terminus.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg - SARS-CoV-2 S1 RBD [orb1108529]
23 kDa; Protein contains amino acids 331-524, two extra amino acids (YS) in N-terminus and His-6 tag at C-terminus.
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg